Publication

학술지 개제논문

SCI 등재 학술지에 게재된 논문 (2014 ~ 2013)

228. Yoo JE, Park YN, Oh BK: PinX1, a telomere repeat-binding factor 1 (TRF1)-interacting protein, maintains telomere integrity by modulating TRF1 homeostasis, the process in which human telomerase reverse Transcriptase (hTERT) plays dual roles. J Biol Chem 2014, 289:6886-6898.
227. Shin NY, Kim MJ, Lee MJ, Han SJ, Koh H, Namgung R, Park YN: Transient elastography and sonography for prediction of liver fibrosis in infants with biliary atresia. J Ultrasound Med 2014, 33:853-864.
226. Marquardt JU, Seo D, Andersen JB, Gillen MC, Kim MS, Conner EA, Galle PR, Factor VM, Park YN, Thorgeirsson SS: Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits. J Hepatol 2014, 60:346-353.
225. Lee IJ, Kim JW, Han KH, Kim JK, Kim KS, Choi JS, Park YN, Seong J: Concurrent chemoradiotherapy shows long-term survival after conversion from locally advanced to resectable hepatocellular carcinoma. Yonsei Med J 2014, 55:1489-1497.
224. Kim YC, Kim MJ, Park YN, Kim KS, Ahn SH, Jung SE, Kim JK: Relationship between severity of liver dysfunction and the relative ratio of liver to aortic enhancement (RE) on MRI using hepatocyte-specific contrast. J Magn Reson Imaging 2014, 39:24-30.
223. Kim SU, Jung KS, Lee S, Park JY, Kim do Y, Ahn SH, Choi GH, Kim KS, Choi JS, Han KH, Park YN: Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma. Liver Int 2014, 34:1008-1017.
222. Kim SH, Park YN, Lim JH, Choi GH, Choi JS, Kim KS: Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma. Eur J Surg Oncol 2014, 40:976-981.
221. Kim JH, Sohn BH, Lee HS, Kim SB, Yoo JE, Park YY, Jeong W, Lee SS, Park ES, Kaseb A, Kim BH, Kim WB, Yeon JE, Byun KS, Chu IS, Kim SS, Wang XW, Thorgeirsson SS, Luk JM, Kang KJ, Heo J, Park YN, Lee JS: Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validation. PLoS Med 2014, 11:e1001770.
220. Kim H, Park YN: Role of biopsy sampling for diagnosis of early and progressed hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2014, 28:813-829.
219. Kim H, Park YN: Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics. Dig Dis 2014, 32:778-785.
218. Kim H, Park SH, Kim EK, Kim MJ, Park YN, Park HJ, Choi JY: Histogram analysis of gadoxetic acid-enhanced MRI for quantitative hepatic fibrosis measurement. PLoS One 2014, 9:e114224.
217. Kim GJ, Seok JY, Rhee H, Choi JY, Choi JS, Kim KS, Thung S, Park YN: beta-Catenin activated hepatocellular adenoma: a report of three cases in Korea. Gut Liver 2014, 8:452-458.
216. Kim GJ, Rhee H, Yoo JE, Ko JE, Lee JS, Kim H, Choi JS, Park YN: Increased expression of CCN2, epithelial membrane antigen, and fibroblast activation protein in hepatocellular carcinoma with fibrous stroma showing aggressive behavior. PLoS One 2014, 9:e105094.
215. Kim BK, Kim HS, Yoo EJ, Oh EJ, Park JY, Kim do Y, Ahn SH, Han KH, Kim SU, Park YN: Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test. Hepatology 2014, 60:1911-1919.
214. Jung KS, Kim JH, Kim SU, Song K, Kim BK, Park JY, Kim do Y, Ahn SH, Moon do C, Song IJ, Choi GH, Park YN, Han KH: Liver stiffness value-based risk estimation of late recurrence after curative resection of hepatocellular carcinoma: development and validation of a predictive model. PLoS One 2014, 9:e99167.
213. Jung KS, Kim BK, Kim SU, Chon YE, Chun KH, Kim SB, Lee SH, Ahn SS, Park JY, Kim do Y, Ahn SH, Park YN, Han KH: Factors affecting the accuracy of controlled attenuation parameter (CAP) in assessing hepatic steatosis in patients with chronic liver disease. PLoS One 2014, 9:e98689.
212. Chon YE, Jung KS, Kim SU, Park JY, Park YN, Kim do Y, Ahn SH, Chon CY, Lee HW, Park Y, Han KH: Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population. Liver Int 2014, 34:102-109.
211. Ahn EY, Yoo JE, Rhee H, Kim MS, Choi J, Ko JE, Lee JS, Park YN: Increased expression of stathmin and elongation factor 1alpha in precancerous nodules with telomere dysfunction in hepatitis B viral cirrhotic patients. J Transl Med 2014, 12:154.
210. Yun WJ, Shin E, Lee K, Jung HY, Kim SH, Park YN, Yu E, Jang JJ: Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma. Pathol Res Pract 2013, 209:568-573.
209. Park JS, Park YN, Lee KY, Kim JK, Yoon DS: P16 hypermethylation predicts surgical outcome following curative resection of mid/distal bile duct cancer. Ann Surg Oncol 2013, 20:2511-2517.
208. Lee SM, Kim HJ, Ha YJ, Park YN, Lee SK, Park YB, Yoo KH: Targeted chemo-photothermal treatments of rheumatoid arthritis using gold half-shell multifunctional nanoparticles. ACS Nano 2013, 7:50-57.
207. Kim H, Yoo JE, Cho JY, Oh BK, Yoon YS, Han HS, Lee HS, Jang JJ, Jeong SH, Kim JW, Park YN: Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers. J Hepatol 2013, 59:746-752.
206. Kim GJ, Kim H, Park YN: Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma. PLoS One 2013, 8:e75449.
205. Kim E, Kang Y, Lee MJ, Park YN, Koh H: Life-threatening lower gastrointestinal hemorrhage in pediatric Crohn's disease. Pediatr Gastroenterol Hepatol Nutr 2013, 16:53-60.
204. Kim E, Kang Y, Hahn S, Lee MJ, Park YN, Koh H: The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice. Korean J Pediatr 2013, 56:19-25.
203. Kim do Y, Chung SI, Ro SW, Paik YH, Lee JI, Jung MK, Lee MG, Park YN, Lee KS, Park JG, Park HD, Han KH: Combined effects of an antioxidant and caspase inhibitor on the reversal of hepatic fibrosis in rats. Apoptosis 2013, 18:1481-1491.
202. Kim BK, Oh HJ, Park JY, Kim DY, Ahn SH, Han KH, Park Y, Yoo EJ, Park YN, Kim SU: Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy. Liver Int 2013, 33:180-189.
201. Jung KS, Chun KH, Choi GH, Jeon HM, Shin HS, Park YN, Park JY: Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: two case reports. BMC Res Notes 2013, 6:520.
200. Jeong HT, Kim MJ, Chung YE, Choi JY, Park YN, Kim KW: Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. AJR Am J Roentgenol 2013, 201:W603-611.
199. Han DH, Choi GH, Kim KS, Choi JS, Park YN, Kim SU, Park JY, Ahn SH, Han KH: Prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiation. J Gastroenterol Hepatol 2013, 28:1384-1390.
198. Di Tommaso L, Sangiovanni A, Borzio M, Park YN, Farinati F, Roncalli M: Advanced precancerous lesions in the liver. Best Pract Res Clin Gastroenterol 2013, 27:269-284.
197. Choi YS, Rhee H, Choi JY, Chung YE, Park YN, Kim KW, Kim MJ: Histological characteristics of small hepatocellular carcinomas showing atypical enhancement patterns on gadoxetic acid-enhanced MR imaging. J Magn Reson Imaging 2013, 37:1384-1391.
196. Balabaud C, Al-Rabih WR, Chen PJ, Evason K, Ferrell L, Hernandez-Prera JC, Huang SF, Longerich T, Park YN, Quaglia A, Schirmacher P, Sempoux C, Thung SN, Torbenson M, Wee A, Yeh MM, Yeh SH, Le Bail B, Zucman-Rossi J, Bioulac-Sage P: Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification. Int J Hepatol 2013, 2013:268625.
195. Bae SH, Sung SH, Oh SY, Lim JM, Lee SK, Park YN, Lee HE, Kang D, Rhee SG: Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation of Keap1 and prevent oxidative liver damage. Cell Metab 2013, 17:73-84.
194. Bae CB, Kim SS, Ahn SJ, Cho HJ, Kim SR, Park SY, Song GW, Kim DJ, Hwang SG, Yang JM, Kim YB, Park YN, Shin SJ, Cho SW, Cheong JY: Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection. J Clin Virol 2013, 58:641-646.
193. Ahn SG, Jeon TJ, Lee SD, Kim SH, Cho HJ, Yun M, Park YN, Lee JD, Park SJ, Kim KS: A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function. Eur J Surg Oncol 2013, 39:964-973.
192. Ahn EY, Kim JS, Kim GJ, Park YN: RASSF1A-mediated regulation of AREG via the Hippo pathway in hepatocellular carcinoma. Mol Cancer Res 2013, 11:748-758.